Literature DB >> 15710464

Nitric-oxide-dependent and independent mechanisms of protection from CNS inflammation during Th1-mediated autoimmunity: evidence from EAE in iNOS KO mice.

Dyana K Dalton1, Susan Wittmer.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) disease was accelerated iNOS-deficient (KO) mice: coinciding with greatly increased numbers of Ag-specific Th1 cells in the periphery that appeared to rapidly shift from the spleen to the CNS during onset of disease symptoms. iNOS KO mice had significantly increased Th1 cells in the CNS versus wild-type mice. Apoptosis of CNS-infiltrating CD4(+) T cells was impaired in iNOS KO mice at peak of disease; consequently, these mice had more CNS-infiltrating CD4(+) T cells. Subsequently, iNOS KO mice up-regulated apoptosis of CNS-CD4(+) T cells. During chronic EAE, CNS macrophages were greatly decreased, suggesting elimination of CNS-infiltrating CD4(+) T cells and activated macrophages by iNOS-independent mechanisms. INOS is not only required for apoptosis of CNS-CD4(+) T cells but also prevents overexpansion of autoreactive Th1 cells in the periphery and the CNS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15710464     DOI: 10.1016/j.jneuroim.2004.11.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  23 in total

1.  Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses.

Authors:  Daniela Giordano; Chang Li; Mehul S Suthar; Kevin E Draves; Daphne Y Ma; Michael Gale; Edward A Clark
Journal:  J Leukoc Biol       Date:  2010-12-22       Impact factor: 4.962

2.  In vitro and in vivo induction and activation of nNOS by LPS in oligodendrocytes.

Authors:  S Y Yao; A Ljunggren-Rose; N Chandramohan; W O Whetsell; S Sriram
Journal:  J Neuroimmunol       Date:  2010-08-19       Impact factor: 3.478

3.  Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system.

Authors:  Richard A O'Connor; Xujian Li; Seth Blumerman; Stephen M Anderton; Randolph J Noelle; Dyana K Dalton
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

4.  Nitric oxide inhibits exocytosis of cytolytic granules from lymphokine-activated killer cells.

Authors:  Marcella Ferlito; Kaikobad Irani; Nauder Faraday; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-20       Impact factor: 11.205

Review 5.  Glial connexins and gap junctions in CNS inflammation and disease.

Authors:  Tammy Kielian
Journal:  J Neurochem       Date:  2008-04-10       Impact factor: 5.372

6.  Nitric oxide regulates BAFF expression and T cell-independent antibody responses.

Authors:  Daniela Giordano; Kevin E Draves; Chang Li; Tobias M Hohl; Edward A Clark
Journal:  J Immunol       Date:  2014-06-20       Impact factor: 5.422

7.  Regulation of type 17 helper T-cell function by nitric oxide during inflammation.

Authors:  Wanda Niedbala; Jose C Alves-Filho; Sandra Y Fukada; Silvio Manfredo Vieira; Akio Mitani; Fabiane Sonego; Ananda Mirchandani; Daniele C Nascimento; Fernando Q Cunha; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

8.  Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models.

Authors:  Marzena J Fabis; Gwen S Scott; Rhonda B Kean; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

9.  Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis.

Authors:  Muzhou Wu; Stella E Tsirka
Journal:  Glia       Date:  2009-08-15       Impact factor: 7.452

10.  S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis.

Authors:  Narender Nath; Osamu Morinaga; Inderjit Singh
Journal:  J Neuroimmune Pharmacol       Date:  2010-01-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.